Prevalence and determinants of iron deficiency in cardiac amyloidosis

Autor: Antoine Jobbé‐Duval, Mélanie Bézard, Stéphane Moutereau, Mounira Kharoubi, Silvia Oghina, Amira Zaroui, Arnault Galat, Coraline Chalard, Elisabeth Hugon‐Vallet, Francois Lemonnier, Damien Eyharts, Elsa Poulot, Pascale Fanen, Benoit Funalot, Valérie Molinier‐Frenkel, Vincent Audard, Luc Hittinger, Marc Antoine Delbarre, Emmanuel Teiger, Thibaud Damy

Publikováno v: ESC Heart Failure, Vol 9, Iss 2, Pp 1314-1327 (2022)

Abstract Aims Iron deficiency (ID) is common in patient with chronic heart failure (HF) and has been widely studied. In contrast, data concerning ID in cardiac amyloidosis (CA) are limited. Amyloidosis is a severe and fatal systemic disease, characte

Externí odkaz: https://doaj.org/article/1655f7014e624439b01d1f60dddf39e8

ARNI Pre-Operative Use and Vasoplegic Syndrome in Patients Undergoing Heart Transplantation or Left Ventricular Assist Device Surgery

Autor: Lamis Haider, Elisabeth Hugon-Vallet, Jean Philippe Constantin, Zakaria Riad, Laurent Sebbag, Nathan Mewton

Publikováno v: Medical Sciences, Vol 10, Iss 1, p 2 (2021)

Background: Vasoplegic syndrome after orthotopic heart transplantation (OHT) or left ventricular assist device (LVAD) implantation is a rare but highly lethal syndrome with complex etiologies. The objective of this study was to assess if the preopera

Externí odkaz: https://doaj.org/article/c4d4ed82ea9d44e3bc02d2aeaa8ea401

Haemodynamic parameters associated with renal function prior to and following heart transplantation

Autor: Nathan Mewton, Elisabeth Hugon-Vallet, Juliette Bourdin, Matteo Pozzi, Nicolas Girerd, Guillaume Baudry, Laurent Sebbag, Patrick Rossignol, Antoine Jobbe Duval

Publikováno v: ESC Heart Failure
ESC Heart Failure, 2021, ⟨10.1002/ehf2.13534⟩
ESC Heart Failure, Vol 8, Iss 6, Pp 4944-4954 (2021)
ESC Heart Failure, Wiley, 2021, ⟨10.1002/ehf2.13534⟩

International audience; Aims: Abnormal renal function is a common feature in patients on heart transplant waiting lists. This study aimed to identify the haemodynamic parameters associated with decreased estimated glomerular filtration rate (eGFR) in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72a8b1b3147414d30e69d7ae12db3653
https://doi.org/10.1002/ehf2.13534

Outcome of Temporary Circulatory Support As a Bridge-to-Left Ventricular Assist Device Strategy in Cardiogenic Shock Patients

Autor: Auriane Bidaut, Erwan Flécher, Nicolas Nesseler, Karl Bounader, André Vincentelli, Mouhammed Moussa, Clément Delmas, Jean Porterie, Karine Nubret, Mathieu Pernot, Michel Kindo, Clément Schneider, Philippe Gaudard, Philippe Rouvière, Magali Michel, Thomas Sénage, Aude Boignard, Olivier Chavanon, Constance Verdonk, Marylou Para, Baptiste Maille, Vlad Gariboldi, Matteo Pozzi, Elisabeth Hugon-Vallet, Pierre-Yves Litzler, Frédéric Anselme, Katrien Blanchart, Gerard Babatasi, Marie Bielefeld, Sandrine Grosjean, Costin Radu, David Hamon, Thierry Bourguignon, Thibaud Genet, Romain Eschalier, Nicolas D’Ostrevy, Hélène Nougue, Anne Cécile Martin, Fabrice Vanhuyse, Hugues Blangy, Christophe Leclercq, Raphael P. Martins, Vincent Galand

Publikováno v: Critical Care Medicine
Critical Care Medicine, Lippincott, Williams & Wilkins, 2022, ⟨10.1097/CCM.0000000000005424⟩
Critical Care Medicine, Lippincott, Williams & Wilkins, 2022, 50 (5), pp.e426-e433. ⟨10.1097/CCM.0000000000005424⟩
Critical Care Medicine, 2022, 50 (5), pp.e426-e433. ⟨10.1097/CCM.0000000000005424⟩

International audience; Objectives: Temporary circulatory support (TCS) as a bridge-to-left ventricular assist device (BTL) in cardiogenic shock patients has been increasing, but limited data exists on this BTL strategy. We aimed at analyzing the out

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::effb998ee1223ae901e152ac90bcb36e
https://hal.archives-ouvertes.fr/hal-03507606

Outcome Predictors and Safety of Home Dobutamine Intravenous Infusion in End Stage Heart Failure Patients

Autor: Nathan Mewton, Matteo Pozzi, Camille Amaz, Antoine Jobbé-Duval, Thomas Bochaton, Laurent Sebbag, Danka Tomasevic, Jean-François Obadia, Guillaume Baudry, Elisabeth Hugon-Vallet, Eric Bonnefoy-Cudraz

Publikováno v: Journal of Clinical Medicine
Journal of Clinical Medicine, MDPI, 2021, 10 (12), pp.2571. ⟨10.3390/jcm10122571⟩
Journal of Clinical Medicine, Vol 10, Iss 2571, p 2571 (2021)
Volume 10
Issue 12
Journal of Clinical Medicine, 2021, 10 (12), pp.2571. ⟨10.3390/jcm10122571⟩

Patients in end-stage heart failure can experiment cardiogenic shock and may not be weanable from dobutamine. The fate of these patients is a challenge for doctors, patients, family, and the institution. Dobutamine use at home can be a solution. The

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5e8a1125d3cd67c54ce52855df9ea0c
https://www.hal.inserm.fr/inserm-03344394/document